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Abstract 
 The synthetic met-enkephalin syndyphalin-33 (SD-33) increases feed intake 
in sheep and recently-weaned pigs. An experiment focused on changes in 
hypothalamic levels of mRNA transcripts from the following genes: µ-opioid 
receptor (MOR), neuropeptide Y (NPY), orexin (hypocretin; HCRT), melanocortin 4 
receptor (MC4R), and agouti-related protein (AGRP). There was no effect of 
treatment on BW or FI at any point in the study. There is a strong positive 
correlation (p <0.001) between MOR and MC4 that remains regardless of treatment 
or time. Weaning resulted in a numerical increase in hypothalamic MOR mRNA 
expression. There was a treatment effect of MOR expression levels 4 days 
postweaning. Hypothalamic NPY expression was unchanged through time or 
treatment. In VEH pigs, weaning resulted in increased hypothalamic expression of 
the HCRT gene at d 1 and d 7 postweaning (P(time) < 0.01). In SD pigs, an increase in 
HCRT expression (relative to d 0) was observed at d 4 postweaning. Expression of 
HCRT did not significantly differ between treatment groups at d 1 and d 4, but 
HCRT expression was greater in VEH pigs than in SD pigs at d 7 (P(time x treatment) < 
0.05). Expression of hypothalamic MC4R did not change through time, but a trend 
(P(treatment) = 0.07) was observed such that expression was less in SD pigs than in 
VEH pigs on d 1 and d 4 postweaning, possibly due to a numerical increase in 
expression in VEH pigs on d 1 relative to d 0.  
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Expression of AGRP was decreased 1 d postweaning in VEH pigs but not in SD 
pigs,. On d 4, levels of AGRP expression were lower in SD pigs than in VEH pigs, 
and lower than d 0 levels as well. On d7, AGRP expression was less in VEH pigs 
than in SD pigs (P(time x treatment) <  0.01). Syndyphalin-33 has the potential to 
alleviate the negative effects of stress during weaning, and has the potential to 
increase feed intake through the melanocortinergic pathway. Further investigation 
is needed to more fully elucidate the complex mechanisms by which syndyphalin-33 
may act to abrogate the post-weaning growth lag in pigs.      
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Introduction 
Syndyphalin-33 (SD-33; Tyr-D-Met(O)-Gly-N-methylphenethylamide) is a 
synthetic enkephalin with prolonged analgesic activity (Kiso et al., 1981). In pigs, 
rats, and sheep, administration of SD-33 via oral, subcutaneous, or intravenous 
routes resulted in transient increases in circulating concentrations of growth 
hormone (GH; Buonomo et al., 1991). Recently, SD-33 was found to increase feed 
intake in adult sheep 48 h after intravenous administration, but this effect was lost 
when the animals were challenged with lipopolysacharide (LPS; Obese et al., 2007). 
In all three studies, the effects of SD-33 relating to analgesia, circulating GH 
concentrations, and appetite were all blocked by naloxone, suggesting that they 
were mediated at least in part through the -opiate receptor.  The discrepancy in 
the timing of effects (immediate analgesia and stimulation of GH, but 48 h before 
significant increases in feed intake) is not yet understood. 
The recently-weaned pig often exhibits decreased feed intake, increased 
susceptibility to disease, and poor growth (Matteri et al., 2000; Kojima et al., 2007; 
Kojima et al., 2008). This post-weaning growth lag can be manifested as mortality, 
particularly in conditions of suboptimal herd health or management. Many factors 
may determine the severity and duration of the post-weaning lag; evidence suggests 
that weaning weight may modulate the expression of key regulators of appetite 
during this period (Kojima et al., 2007). 
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Preliminary data in our lab suggests that a single intramuscular injection of 
syndyphalin-33 can increase feed intake in the recently-weaned pig (Kojima et al., 
submitted). SD-33 may offer some protection during the weaning process, 
compensating for an extreme decrease in appetite, and increasing overall health 
and well being of the animal during this critical period. 
As an opioid molecule, SD-33 likely influences the regulation of expression of 
many appetite-regulating genes. An experiment was conducted to investigate the 
potential for SD-33 to alter hypothalamic expression of key appetite-regulating 
genes during the first 7 d postweaning. The experiment focused on changes in 
hypothalamic levels of mRNA transcripts from the following genes: µ-opiate 
receptor (MOR), neuropeptide Y (NPY), orexin (hypocretin; HCRT), melanocortin 4 
receptor (MC4R), and agouti-related protein (AGRP).    
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Literature Review 
Syndyphalin-33 
Syndyphalin-33 (SD-33; Tyr-D-Met(O)–Gly-N-methylphenethylamide) was first 
synthesized in 1981 by scientists at the University of Tokushima, Japan (Kiso et al., 
1981). A tripeptide, SD-33 represents the ―minimal segment‖ of Met-enkephalin (an 
endogenous opioid peptide) that exhibits prolonged analgesic activity (Baulieu and 
Kelly, 1990). To evaluate the similarity of SD-33 to morphine, another opioid 
compound known for its analgesic properties, the authors conducted a tail-flick test 
in mice. A single subcutaneous injection of SD-33 was administered at 2, 4 and 8 
mg/kg, doses comparable to 1, 2 and 4 mg/kg injections of morphine, respectively. 
The tail-flight response (in seconds) was recorded over a period of 180 minutes. SD-
33 was similar to morphine in both the potency and duration of analgesia. The 
authors believed that although SD-33 no longer resembled an enkephalin, its ability 
to be stable in the mouse model made it a valuable opioid peptide. 
Buonomo and colleagues evaluated the effect of syndyphalin-33 on the release of 
growth hormone in sheep, pigs and rats (Buonomo et al., 1991). Sheep were injected 
intravenously with SD-33 in a dose of .05, .10 and .20 µmol/kg. As compared to 
controls, GH (measured in ng/ML) was elevated in all groups five minutes after i.v. 
injection and remained elevated for 45 minutes. When sheep were given the i.v. 
injections two hours apart, SD-33 treated animals again had significantly higher 
GH levels than did control animals. Rats and 40-kg pigs were given a single 
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subcutaneous injection of 0.0, 0.50, 1.0 and 2.0 µmol/kg or 0.0 or 0.50 µmol/kg SD-
33, respectivel. Plasma GH concentrations were elevated in treated pigs relative to 
controls in a dose dependent manner, peaking at 30 minutes postinjection and 
remaining elevated at 60 minutes postinjection. Rats were given an oral gavage of 
SD-33 in a dose of 0.0, 1.0, 10.0 or 100.0 µmol/kg. An increased in GH levels was 
observed within 15 minutes, and for the rats given the dose of 100.0 µmol/kg, 
remained elevated for 2 hours post-administration. Pigs were given an oral gavage 
of SD-33 in a dose of 0.0, 0.125, 0.50 or 2.0 µmol/kg. The GH levels were elevated for 
all treatment groups relative to controls within 30 minutes of administration and 
remained elevated for two hours. To determine if SD-33 was actually working 
through the - opiate receptor, the authors challenged rats with both SD-33 and the 
opioid antagonist naloxone. Naloxone was able to completely block the elevation of 
GH concentrations by SD-33 at both the 1.0 and 10.0 mg/kg dose.  
In 2007, Obese and others evaluated the effect of syndyphalin-33 on long-term 
feed intake in sheep (Obese et al., 2007). Three experiments were performed. Sheep 
were given an intravenous injection of SD-33 at a dose of 0.0, 0.05 or 0.1 µmol/kg. 
Feed intake was measured for 48 hours. Feed intake at 24 hours was greater in 
sheep receiving 0.1 µmol/kg dose of SD-33 relative to controls. After 48 hours, both 
the 0.1 and 0.05 µmol/kg groups had eaten significantly more feed than the control 
group. The next experiment tested the ability of naloxone to block the effects of SD-
33. Naloxone was effective in blocking the stimulatory effect of SD-33 on feed 
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intake. Lastly, sheep were given either saline or SD-33 in conjunction with or 
without an immune challenge in the form of lipopolysaccharide (LPS. There was no 
difference in intake in LPS-challenged sheep with or without SD-33: although SD-
33 increased the feed intake of adult sheep, it did not counteract the decrease in FI 
associated with an immune challenge. 
Weaning 
Currently, pigs are weaned (separated from the dam) at approximately 21 days 
of age, depending on the particular management practices of the facility (Holden 
and Ensminger, 2006). The stress of weaning causes reduced weight gain or actual 
weight loss directly after weaning. In addition to the stress of being separated from 
the dam, change to an unfamiliar food source and an unfamiliar way of obtaining 
that food also lead to weight loss (Libbrandt et al., 1975; Bark et al., 1986). The age, 
weight, and sex of the animal are all factors contributing to how severely the animal 
is affected by the stressors of weaning (Libbrandt et al., 1975; Cooper et al., 2009). 
Weaning also causes the animal to become immunosupressed (Kojima et al., 2008). 
There is an increase in somatotropin (GH) concentrations and a decrease in IGF-I 
and IGF-II (Carroll et al., 1998; Matteri et al., 2000). After weaning, there is 
increased plasma and urinary levels of cortisol concentrations as well as decreased 
plasma corticosteroid-binding globulin (Le Dividich and Seve, 2000; Heo et al., 2003; 
Kojima et al., 2008). Factors such as weaning weight and sex also attribute to the 
immune status of the piglet (Matteri et al., 2000; Bruininx et al., 2001; Kojima et 
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al., 2007; Cooper et al., 2009). Mortality rate in the nursery phase (defined as the 
period from weaning to 60 lbs.) was 2.9% in 2006 (USDA, 2008). The causes of death 
are listed in table 1. 
Appetite  
The regulation of appetite is important in maintaining energy balance in the 
body. The role of the hypothalamus in appetite has been extensively reviewed by 
Arora and Anubhuti (2006). The hypothalamus can be broken down into several 
regions, or ―nucleii‖. The arcuate nucleus controls the body’s energy balance and is 
the feeding control center, integrating various hormonal signals (Funahashi et al., 
2000). The arcuate nucleus produces neuronal peptides such as Neuropetide Y  
(NPY), Agouti-related protein (AGRP) and -melanocyte stimulating hormone  ( -
MSH; Arora and Anubhuti 2006). The paraventricular nucleus integrates signals 
from the thyroid and the hypothalamic-pituitary axis involved in nutrition. Some of 
the neuronal pathways that communicate between the two include NPY, orexin, 
and -MSH (Neary et al., 2004). The ventromedial nucleus of the hypothalamus is a 
target for leptin and acts as a center for controlling satiety (Satoh et al., 1997). The 
dorsomedial hypothalamic area processes information from other areas of the 
hypothalamus such as the medial and lateral hypothalamic nuclei, and also 
produces orexins (Elmquist et al., 1998). In addition, the lateral hypothalamic area 
contains glucose-sensitive neurons that help regulate feeding and produces orexins 
(Bernardis et al., 1996). The brain stem includes the nucleus of tractus solitaries 
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(NTC). The NTC contains a high number of NPY-binding sites, and controls the 
frequency of meals as well as the size of meals, and gives fullness signals once the 
meal is complete (Harfstrand et al., 1986; Kawai et al., 1984; Williams et al., 2001). 
A schematic representation of each area of the hypothalamus and the hypothalamic 
and peripheral neuropeptides associated with each is shown in figure 1.       
Opioids and Opioid Receptors 
The body produces endogenous opioids that can be classified into three families. 
Each family of ligands is produced by a single gene. These genes are the 
proopiomelanocortin, proenkephalin and prodynorphin genes (Akil et al., 1984). 
There are three classical opioid receptor types: mu (µ), kappa (k), and delta ( ). All 
three of the opioidreceptor subtypes are involved in analgesia (Zöllner and Stein, 
2007). Synthetic opioids such as morphine can also bind to the opiate receptors and 
have similar effects to endogenous opioids (Kiso et al., 1981). 
An extensive review by Bodnar (2004) describes how endogenous opioids affect 
feeding behavior and appetite. Agonists of all three opioid receptor types have been 
shown to increase feed intake (Lowy et al., 1983; Gosnell et al., 1986). The route by 
which these effects occur can be through changes in transcription and/or activity of 
AGRP, NPY, peptide YY and the melanocortin 3 and 4 receptors (Olszewski et al., 
2001; Kotz et al., 1993; Hagan et al., 1993; Grossman et al., 2003). According to 
Glass (1999), opioids produced in different parts of the brain cause differing types of 
food responses. Opioids in the hindbrain are classified as sensory and metabolic in 
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nature, whereas opioids associated with the amygdala regulate the emotional 
response to food, and opioids in the hypothalamus are associated with maintaining 
homeostasis (Glass et al., 1999). The effect that opioids have on the appetite 
pathway can change depending on the energy needs of the animal (Margules et al., 
1978).      
Effects of stress and opiates on µ-opioid receptor expression 
During stress, the body will release endogenous opioids, and decrease the 
number of available opioid receptors through negative feedback mechanisms 
(Seeger et al., 1984). In some cases however, stress can increase expression of the µ-
opioid receptor, as was observed in young rats experiencing stress due to hot plate 
exposure (Torda et al., 1978). In the hypothalamus of these rats, the numbers of 
opiate receptor sites were significantly higher than controls. The authors speculated 
that stressing the young underdeveloped brain of these animals led to the 
development of an over-functioning defense system. 
Effects of Stress and Opioids on Specific Appetite Regulators 
Neuropeptide Y (NPY) is a 36 amino acid hypothalamic peptide that exhibits 
appetite-stimulating activity (Tatemoto et al., 1982; Billington et al., 1991). The 
mRNA expression of NPY increased in the arcuate nucleus of the hypothalamus in 
rats when deprived of food and during periods of food restriction. The change in 
NPY mRNA expression was most notable in the male rats as compared to females 
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in this particular study (Brady et al., 1990). Hypothalamic NPY gene expression 
was 88% higher in ewe lambs that were nutrient-deprived as compared to lambs 
that were adequately nourished (McShane et al., 1993). The weanling pig produces 
NPY in a body weight-dependent manner, such that pigs with greater weaning 
weights have increased NPY mRNA levels 4 days postweaning (Kojima et al., 2007). 
Stress will alter the expression of NPY: when rats are stressed, they exhibit 
increased expression of NPY in the arcuate nucleus (Makino et al., 2000). Appetite 
is stimulated by µ-opioid agonists through up-regulating activity of NPY (Kotz et 
al., 1993; Pomonis et al., 1997; Dodo et al., 2005). Rats that were injected 
simultaneously with NPY and a - and -opioid receptor antagonist showed 
decreased feed intake while the same injections with a -opioid receptor antagonist 
showed no effect on feed intake (Kotz et al., 1993). In male rats, the increase in feed 
intake caused by the injection of NPY directly into the paraventricular nucleus 
could be blocked with naloxone (Pomonis et al., 1997). In male broiler chicks, a 
similar study was performed to investigate the effects of -, - and -opioid receptor 
antagonists on NPY-induced feeding. In agreement with Kotz et al. (1993), the most 
dramatic effects were seen when the -opioid receptor antagonist was administered 
(Dodo et al., 2005). These studies indicate that the -opioid receptor in particular, 
and possibly others, is effecting NPY-induced feeding.      
The hypocretin or prepro-orexin gene produces two products, orexin-A and 
orexin-B. While only 46% similar in amino acid sequence, both orexin-A and orexin-
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B will stimulate feed intake when administered directly into the hypothalamus of 
rats (Sakurai et al., 1998). Also, the mRNA of these peptides is up-regulated when 
rats are fasted, indicating their role in the appetite pathway (Sakurai et al., 1998). 
Increased feed intake has also been observed in pigs when given an intramuscular 
injection of orexin-B (Dyer et al., 1999), and in sheep when given orexin-B 
intravenously (Sartin et al., 2001). The weanling pig produces orexin in a body 
weight dependent manner, such that pigs with grater weaning weights have greater 
mRNA levels of orexin 4 days postweaning (Kojima et al., 2007). Stress can affect 
orexin production: immobilization stress in young rats will increase mRNA 
expression levels of orexin (Ida et al., 2000). The administration of morphine in mice 
depressed the hyprocretin/orexin arousal system (Li et al., 2008). 
The melanocortin 4 receptor (MC4R), one of five melanocortin receptors. is a G 
protein-coupled receptor found throughout the central nervous system. Opioiods will 
decrease expression of the MC4R gene (Chaki et al., 2005). The 
Proopiomelanocortin (POMC) gene products -MSHia an MC4R agonist, while 
agouti-related protein (AGRP) is an MC4R antagonist (Cone, 2005). When -MSH is 
bound to MC4R there is an appetite-suppressing effect on feed intake; this effect 
can be blocked by the antagonist AGRP (Kalra et al., 1999). Agouti-related protein 
is a neuropeptide produced by the same neurons of the hypothalamus that produce 
NPY and has potent appetite stimulating properties that are long lasting (Shutter 
et al., 1997; Ollmann et al., 1997). Outside of the melanocrotin pathway, the variant 
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AGRP-(18-132) has long lasting orexinogenic effects that may involve the regulation 
of as yet unidentified gene products at transcriptional, translational and/or post-
translational levels (Hagan et al., 2000). Pigs with heavier weaning weights have 
greater levels of hypothalamic AGRP mRNA 4 days postweaning when compared to 
pigs with lighter weaning weights (Kojima et al., 2007). Stress will effect the 
interactions between MC4R, AGRP, and -MSH (collectively known as the 
melanocortin system). In rats, AGRP mRNA expression in the arcuate nucleus is 
decreased following a stressful event, contributing to increased sensitivity for -
MSH and subsequent decreased feed intake (Kas et al., 2005). Forced swimming 
and restraint in rats increased POMC gene expression and suppressed feeding, but 
pretreatment with an MC4R antagonist blocked the anorectic and anxiogenic effects 
of these stressors, suggesting that the melanocortinergic pathway is heavily 
involved in stress-related anorexia (Liu, 2007). 
A model using opiate administration to alleviate stress has been investigated in 
infant Rhesus monkeys. Opiate administration was found to be an effective method 
of elevating separation-induced stress in these animals (Kalin et al., 1988). 
Administration of morphine and fentanyl (both µ-opioid receptor agonists) during a 
surgical procedure resulted in decreased postoperative cortisol concentrations 
relative to controls in young (20 kg) pigs (Malavasi et al., 2006), but it is unclear if 
this was due to a direct effect of the opioids or a response to differing levels of post-
operative pain (an indirect effect due to the analgesic properties of the opioids). 
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Conclusions 
The appetite pathway is disrupted by the stress of weaning in the young pig. 
Opiates may represent a novel mechanism to ease the stress of weaning, increase 
feed intake, and increase overall production gains. The following experiment 
explores the effects of the synthetic opioid syndyphalin-33 on weaning stress and 
appetite regulators in the pig. 
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Materials and Methods 
All animal procedures were reviewed and approved by the University of 
Tennessee Animal Care and Use Committee. 
Animals and diets 
Crossbred pigs (Landrace X Duroc X Hampshire) were farrowed in standard 
farrowing pens and processed according to usual University of Tennessee 
Experiment Station practice between 4 and 7 d of age. Standard processing 
procedures included needle teeth clipping, tail docking, iron supplementation, ear 
tagging, and castration of males. Piglets were kept in farrowing pens with their 
dams until weaning, with creep feed (Diet 554PE, Tennessee Farmers Cooperative, 
La Vergne, TN) available after 7 d of age.  
Experimental Design 
On day 0 (weaning day), 77 pigs (barrows and gilts, 19 + 3 d of age, 7.16 + 1.03 
kg, 3 replications) were removed from the dam, weighed and allocated into four time 
groups: d 0 (weaning day), and d 1, 4 and 7 (postweaning). Tissue samples were 
collected on d 0 from unweaned animals (n = 19) and were considered a pre-weaning 
baseline. The remaining groups were further allocated into the following treatment 
groups: SD, receiving 0.5 µmole/kg SD-33 in a single intramuscular injection of 0.5 
mL or less of saline; or VEH, receiving a single intramuscular injection of 0.5 mL 
saline. After administration of treatments, animals were weaned into individual 
pens (1.3 m2) with nursery feed and water provided ad libitum. Body weight and 
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feed intake measurements were taken on d 1, 4 and 7 post-weaning, and average 
daily feed intake was calculated for each interval. Tissue samples were collected on 
d 1, 4 and 7 on animals within each treatment group (n = 8 or 9).  
Tissue Collection and Processing 
Animals were humanely euthanized and the hypothalamus was collected as 
previously described (Kojima et al., 2007) and stored in 5 mL RNAlater solution 
(Ambion, Forest City, CA) at -20°C until processed. For the isolation of mRNA from 
hypothalamus, tissue samples were homogenized in 10-20 volumes of TRI Reagent 
Solution (Ambion, Foster City, CA) and allowed to incubate for 5 minutes. After 
homogenization, bromochloropropane and isopropanol were used to extract total 
mRNA. Samples were then washed with ethanol and suspended in RNAse-free 
water. To remove DNA contamination, samples were incubated with DNAse using 
the Turbo DNA-Free kit (Ambion, Forest City, CA).  Reverse transcription was 
performed with the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Forest City, CA) as per manufacturer recommendations.  All cDNA 
samples were characterized (concentration and 260/280 nm absorbance ratio) and 
stored at -20°C until gene expression analysis was performed.  
Gene Expression Analysis 
Gene expression in the hypothalamus was analyzed using the quantitative real-
time polymerase chain reaction technique with the following parameters: 2 min at 
50°C, 8.5 min at 95°C, 45 cycles of 15 sec at 95°C followed by 1 min at 60°C, 
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indefinite hold at 4°C. For each gene of interest, primer efficiency was determined 
using a dilution series as described by Pfaffl  (2001). In each reaction, a total volume 
of 20 µl was used including 10 µl Applied Biosystems Gene Expression Master Mix 
(Forest City, CA), 7 µl water, 2 µl cDNA template, and 1 µl Taqman Gene 
Expression assay primer/probe mix (Applied Biosystems, Forest City, CA). Table 1 
shows the primer and probe sequences, efficiency and amount of cDNA used for 
each gene of interest. Threshold values were chosen so that data points were 
measured in the log section of the fluorescence curve. Each sample was run in 
duplicate, with the final CT value being the average of both readings. The selected 
internal reference was 18S rRNA, and all target genes were normalized to it by 
calculating ΔCT. The ΔCT value was then transformed linearly as described by Livak 
and Schmittgen (2001) to obtain a relative expression value. 
Statistical Analyses 
Variables were analyzed in SAS using mixed model analysis of variance. Log 
transformations were performed on gene expression variables to maintain 
homogeneity of variance. Pig was the experimental unit. Body weight and daily feed 
intake were analyzed with repeated measures. Correlations and their associated 
values were analyzed for relationships among pre-weaning body weight and 
appetite genes both pre-weaning and 24 hours post weaning. A scatter plot and 
related correlation value were obtained for MC4R and MOR over all treatment 
groups. Gene expression data was analyzed with time and treatment as main effects 
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and the interaction between the two factors was also evaluated. Least squares 
means were compared using Fisher’s protected least significant difference. A 
significance level of P < 0.05 was used for all testing; trends were reported if P < 
0.10. Preliminary analysis detected no replicate effect, and so replicate was removed 
from the model. Pre-weaning body weight and sex were evaluated as covariates and 
were found to have no effect and were removed from the model. All figures depict 
raw means and standard errors. 
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Results 
Feed Intake and Body Weight 
As expected, average daily feed intake in VEH and SD pigs was minimal during 
the first 24 h post-weaning (Figure 2). Increases in average daily feed intake were 
evident for both treatment groups when measured from d 1 to d 4, and from d 4 to d 
7, relative to the previous interval (P < 0.05). No significant difference in average 
daily feed intake due to treatment was observed at any time. Body weighs of pigs in 
both treatment groups remained unchanged 1 d postweaning relative to d 0 weights 
(Figure 3). Similar to what was seen in average daily gain, increases in body weight 
were evident for both treatment groups when measured from d 1 to d 4, and from d 
4 to d 7, relative to the previous interval (P < 0.05). No significant difference in body 
weight due to treatment was observed at any time. 
Gene Expression 
Weaning resulted in a numerical increase in hypothalamic MOR mRNA 
expression on d 1 and d 4 post-weaning in VEH pigs such that on d 4, MOR 
expression was significantly greater in VEH pigs than in SD pigs (P < 0.05; Figure 
4). There was no difference between MOR expression levels in SD pigs at any time, 
although a numerical decrease in expression at d 4 contributed to the difference in 
expression observed between treatment groups at that time (P(time x treatment) = 0.01). 
Expression of MOR at d 7 did not differ between treatment groups or from pre-wean 
levels.  
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Hypothalamic NPY expression was unchanged through time or treatment, but a 
trend (P(time x treatment) = 0.07) was observed such that while NPY expression was less 
in SD than VEH pigs at d 1 and d 4 postweaning, expression was greater in SD pigs 
compared to VEH pigs at d 7 (Figure 5).  
In VEH pigs, weaning resulted in increased hypothalamic expression of the 
HCRT gene at d 1 and d 7 postweaning relative to pre-wean levels (P(time) < 0.01; 
Figure 6). In SD pigs, an increase in HCRT expression (relative to d 0) was observed 
at d 4 postweaning. Expression of HCRT did not significantly differ between 
treatment groups at d 1 and d 4, but HCRT expression was greater in VEH pigs 
than in SD pigs at d 7 (P(time x treatment) < 0.05). 
Expression of hypothalamic MC4R did not change through time, but a trend 
(P(treatment) = 0.07) was observed such that expression was less in SD pigs than in 
VEH pigs on d 1 and d 4 postweaning, possibly due to a numerical increase in 
expression in VEH pigs on d 1 relative to d 0 (Figure 7). Levels of expression of 
MC4R were not different from d0 levels in either treatment group at d4 or d7 post-
weaning.    
Expression of AGRP was decreased 1 d postweaning in VEH pigs but not in SD 
pigs, relative to d 0 (Figure 8). On d 4, levels of AGRP expression were lower in SD 
pigs than in VEH pigs, and lower than d 0 levels as well. On d7, AGRP expression 
was less in VEH pigs than in SD pigs at that time, and less than prewean levels as 
well (P(time x treatment) <  0.01). 
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Correlations 
 Relationships between body weight and expression of appetite genes at d 0 
(pre-weaning) were evaluated (Table 3). Body weight was positively associated with 
MC4R expression (r = 0.544; p = 0.0146), and tended to be positively associated with   
MOR expression (r = 0.404; p = 0.0865). A strong positive correlation (r 0.801; p < 
0.0001) existed between MC4R and MOR. Expession of NPY tended to be positively 
correlated with MC4R expression (r = 0.418; p = 0.0753), and was positively 
associated with MOR expression (r = 0.694; p = 0.0006). Expression of HCRT was 
found to be positively associated with AGRP expression (r = 0.818; p < 0.0001). 
 Correlations between transcript abundance of appetie genes was assessed at 
1 d postweaning were also evaluated (Table 4). A positive relationship between 
expression of MC4R and MOR was observed at 1 d postweaning (r = 0.515; p = 
0.0333), and a trend where MC4R and NPY expression were positively associated 
was also noted (r = 0.421; p = 0.0930). There was a strong positive correlation (r = 
0.764; p = 0.0002) between expression of MC4R and HCRT. Additionally, positive 
relationships were also observed between MOR and NPY expression (r = 0.612; p = 
0.0077) and between HCRT and AGRP expression (r = 0.604; p = 0.0051). 
 A strong positive correlaton between expression of MOR and MC4R existed 
across time and treatment (r = 0..665; p < 0.001; Figure 9).  
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Discussion 
Inhibition of piglet growth rate caused by weaning is well recognized and clearly 
associated with reduced feed intake (Bark et al., 1986; McCracken et al., 1995). In 
this experiment, weaning resulted in low feed intake and no weight gain over the 
first day postweaning, but pigs recovered so that both average daily feed intake and 
body weights were greater by d 4 and were still increasing by d 7. We did not 
observe an increase in average daily feed intake or body weight due to treatment 
with syndyphalin-33, although feed intake was numerically higher in SD animals 
after d 1. In a previous study in which pigs were given syndyphalin-33 then weaned 
into group pens, cumulative feed intake did not significantly increase (relative to 
intake of controls) until 9 d postweaning (Kojima et al., submitted). Obese et al. 
(2007) observed an increase in feed intake 48 h postinjection in adult wethers 
injected i.v. with SD-33 at a dosage of 0.05 mmole/kg. Differences in the timing of 
response may arise due to differences in age, species, route of administration, 
dosage, and level of concurrent stress. It should be noted that in both growing pigs 
(50 kg barrows; Buonomo et al., 1991) and recently-weaned pigs (Kojima et al., 
submitted), a single injection of SD-33 at 0.5 µmole/kg resulted in similar increases 
in circulating growth hormone. The mechanism behind the prolonged, cumulative 
effect on feed intake is unclear. The actions of SD-33 on regulation of hypothalamic 
gene expression may occur much earlier than when the actual outcome (increased 
feed intake) is observed. 
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The stress of weaning numerically increased expression of the µ-opiate receptor 
in VEH pigs on d 1 and d4, but this was not evident in SD pigs; indeed, by d 4 the 
difference in expression levels between VEH and SD pigs was significant. While 
there is some evidence that stress (and subsequent release of endogenous opioids) 
would predict a down-regulation of the opiate receptors (Seeger et al., 1984), this 
response may be dependent on age. In young rats experiencing stress due to hot 
plate exposure, opiate receptor levels in the hypothalamus were significantly higher 
in the stressed animals as compared to controls. It was speculated that by stressing 
the young underdeveloped brain of these animals, the development of an over 
functioning defense system arose (Torda et al., 1978). Obese et al. (2007) observed 
that the increase in feed intake in adult wethers by SD-33 was blocked by naloxone, 
suggesting that the effect was mediated (at least in part) through µ-opiate 
receptors. In the present study, a down-regulation of hypothalamic MOR expression 
was observed in SD pigs relative to VEH pigs at d 4, supporting the notion that SD-
33 binds the µ-opiate receptor as µ-opioids will readily down-regulate their 
receptors by many different mechanisms, including modulation of gene expression 
(Gach et al., 2008). It is impossible to say when the down-regulation first occurred, 
although it is tempting to speculate that it had actually began prior to sample 
collection at d 1, as evidenced by the numerical difference between treatment 
groups at that time. By d 7, MOR expression in VEH pigs had decreased to its 
lowest observed level while expression in SD pigs was no different from pre-wean 
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levels, suggesting that homeostatic mechanisms may have been activated to 
alleviate the effects of both weaning and SD-33 on MOR expression.  
In the present study, a trend was observed where weaning tended to increase 
expression of NPY in VEH pigs more than in SD pigs at d 1 and d 4 postweaning, 
but NPY expression had decreased to pre-weaning levels by seven days postweaning 
in those animals. The expression patterns of NPY during the weaning process in the 
pig are largely unknown. Previously, we found that hypothalamic NPY mRNA 
expression at 4 d postweaning was positively associated with weaning weight 
(Kojima et al., 2007). When rats are stressed they also exhibit increased expression 
of NPY in the arcuate nucleus (Makino et al., 2000). Expression of NPY in SD 
animals did not appear to fluctuate over the course of the study. Opioid agonists 
have been shown to stimulate feed intake by up-regulating activity of NPY (Kotz et 
al., 1993; Pomonis et al., 1997; Dodo et al., 2005). It is possible that we missed 
modulation of expression that occurred before or after the times we chose for tissue 
collection. It is also unclear if the apparent increase in NPY expression in VEH pigs 
is a consequence of stress or a response to hunger, as transcription activity of the 
NPY gene will increase during fasting or feed-restriction (Shimokawa et al., 2003; 
minor et al., 2009).  
Orexin (hypocretin) will increase feed intake in pigs (Dyer et al., 1999) as well as 
many other animals (as reviewed by Benoit et al., 2008). Similar to NPY, post-
weaning levels of HCRT expression are dependant to some extent on weaning 
weight, such that heavier pigs have greater hypothalamic expression of HCRT 
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(Kojima et al., 2007). A stressful event such as immobilization stress in young rats 
will increase transcript abundance of HCRT (Ida et al., 2000). Here, the stress of 
weaning increased HCRT expression at d 1 and d 7 postweaning in VEH pigs, but 
not in SD pigs. Treatment with SD-33 may have resulted in the down-regulation of 
HCRT expression; Li and van den Pol (2008) showed that exogenous opiates such as 
morphine will depress the hyprocretin/orexin arousal system.  
Stress, in particular electrical foot shock in rats, will increase expression of the 
MC4R gene (Yamono et al., 2004). Opiates, on the other hand, will decrease 
expression of MC4R (Chaki et al., 2005). This coincides with what was observed 
when piglets where weaned and treated with SD-33. We observed an increase in 
MC4R expression due to weaning 1 d after the piglet was removed from the sow, but 
this increase was negated when the piglet received treatment with SD-33 at 
weaning. By 4 d postweaning, MC4R expression had essentially returned to pre-
weaning levels in both treatment groups. 
Agouti-related protein is an MC4R antagonist (Cone, 2005) and will increase 
feed intake (as reviewed by Pritchard and White, 2005). The stress of weaning 
caused an increase in expression of AGRP on day one followed by a sharp decrease 
in expression on day four followed by an increase by seven days post weaning. A 
stressful event will decrease the expression of AGRP (Kas et al., 2005). Opiates 
have been shown to increase activity of AGRP (Hagan et al., 2001). In the present 
study, we also observed an increase in the expression of AGRP due to the effects of 
an opiate. 
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The (83-132) splice variant of AGRP has long lasting orexinogenic effects (Hagan 
et al., 2000). We observed changes in AGRP and MC4R expression levels due to SD-
33 at 1 d postinjection, yet previous studies in sheep (Obese et al., 2007) and pigs 
(Kojima et al., submitted) consistently describe a delayed response in feed intake. 
Hagan et al. (2000) suggests that the prolonged effects of AGRP - (83-132) may stem 
from its role in regulating transcription and synthesis of other proteins further 
downstream in the appetite pathway. Interestingly, AGRP has also been shown to 
increase activity at opioid receptors. When AGRP– (82-132) was given 
simultaneously with naloxone, the short-term orexinogenic affects of AGRP– (82-
132) were decreased, but the long-term effects were not altered (Hagan et al., 2001). 
Although modulation of opioid action by AGRP – (82-132) appears to be of a short 
duration, it may contribute to the overall effects of SD-33. It is important to note 
that the primers we used for quantitating expression of AGRP were not designed to 
be specific for a particular splice variant, and so any effect of SD-33 on AGRP – (82-
132) abundance is unkown. 
Obese et al. (2007) observed that the increase in feed intake by SD-33 was 
blocked by naloxone, suggesting that the effect was mediated through µ-opioid 
receptors. Appetite is stimulated by µ-opiate agonists in many ways: by 
upregulating activity of the appetite stimulators AGRP and NPY (Hagan et al., 
2001; Brugman et al., 2002) and by decreasing synthesis of the appetite suppressor 
-melanocyte stimulating hormone ( -MSH), a product of the proopiomelanocortin 
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(POMC) gene (Wardlaw et al., 1996). Opiates also act to decrease expression of the 
MC4R gene, the product of which is the receptor which binds both -MSH and 
AGRP (Chaki et al., 2005). Stress also regulates the expression of many of these 
regulators of appetite. Kas et al. (2005) observed that in rats, AGRP mRNA 
expression in the arcuate nucleus is decreased following a stressful event, 
contributing to increased sensitivity for -MSH and subsequent decreased feed 
intake.  Liu et al. (2007) observed that forced swimming and restraint increased 
POMC gene expression and suppressed feeding, but pretreatment with an MC4R 
antagonist blocked the anorectic and anxiogenic effects of these stressors, 
suggesting that the melanocortinergic pathway is heavily involved in stress-related 
anorexia. 
Several positive relationships were found to exist between body weight and the 
expression of appetite-regulating genes prior to weaning. Body weight was 
positively correlated with MC4R and MOR on d 0. But these become uncoupled at 
24 h postweaning.  
The positive relationships between MC4R and NPY, MOR and NPY, and HCRT 
and AGRP remain through the first 24 hours of weaning. The positive relationship 
between HCRT and MC4R becomes apparent 24 hours after weaning. This may be a 
result of the stress of weaning, as stress has been shown to increase transcriptional 
activity of both of these genes (Ida et al., 2000; Yamano et al., 2004).  We observed a 
strong correlation between MC4R and MOR expression across all time and 
treatment, supporting the concept that the melanocortinergic pathway is influenced 
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by opiod tone at all times. This is in agreement with Chaki et al. (2005) who 
observed that opioids down-regulated MC4R expression. As an opioid agonist, SD-
33 would be expected to down-regulate transcription of its receptor as well as 
MC4R, resulting in a positive association between the expression of those two 
genes. 
Opioid administration was found to be an effective method of elevating 
separation-induced stress in infant rhesus monkeys separated from their mothers 
(Kalin et al., 1988), and in speeding post-operative recovery (including recovery of 
appetite) in young (20 kg) pigs (Malavasi et al., 2006). Similarly, the synthetic 
enkephalin SD-33 also has the potential to alleviate the negative effects of stress 
during weaning in pigs, and has the potential to increase feed intake through effects 
on the melanocortinergic pathway. Further investigation is needed to more fully 
elucidate the complex mechanisms by which syndyphalin-33 may act to abrogate 
the post-weaning growth lag in pigs.    
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Table 1. Percentage of Nursery Pig Deaths by Producer-identified Causes in 20061 
Cause      %     Std. Error 
Scours     12.5      1.1 
Starvation     9.8      0.9 
Respiratory Problems   44.2      2.3 
CNS/Meningitis    18.7      1.9 
Other identified problems  4.1      0.8 
Unknown problem    10.7      1.1 
Total      100 
 
1 Adapted from (USDA, 2008) 
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Table 2. Details of primers and probes used for real-time PCR 
 
Gene1  Forward Primer Sequence               Reverse Primer Sequence                   Probe Sequence    Efficiency      Concentration 
                     (%)                  (ng/µl) 
 
18-S2 GGCCTGCTTTGAACACTCTAATTTT  CCCCTCGATGCTCTTAGCT  CCCCGCGGGACACT     102 25.00 
18-S3 GGCCTGCTTTGAACACTCTAATTTT CCCCTCGATGCTCTTAGCT  CCCCGCGGGACACT     102 1.00 
18-S4 GGCCTGCTTTGAACACTCTAATTTT CCCCTCGATGCTCTTAGCT  CCCCGCGGGACACT        94 10.00  
MC4R GTAATTCCATCATCGATCCCCTGAT GGGATAGCAACAGATGATCTCTTTGA   CCGGAGCCAAGAACT     104 25.00 
MOR TGGTCTGCCTGTGATGTTCATG  GGTGAGAGAATGTTAGTGCACAATC AACCATTCCGGTACTTTGT     97 25.00  
NPY TCGGCGTTGAGACATTACATCA  GTCTCGGGACTAGATCGTTTTCC CACCAGGCAGAGATAC     105 1.00 
HCRT GGCCGGCATCCTCACT   GCAGCCGGCCTTGCA    CCGCCGCTTGCCCA         92 1.00 
AGRP GCAGGCCGAGGCCAA   CGTGCCTTGCGTCCTTC  CAGAGGTGCTAGATCCT   85 10.00 
           
1MC4R = Melanocortin 4 Receptor; MOR= µ-Opiate Receptor; NPY = Neuropeptide Y; HCRT = Hypocretin; 
AGRP = Agouti Related Protein. 
2Used to normalize MC4R and MOR. 
3Used to normalize NPY and HCRT. 
4Used to normalize AGRP. 
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Table 3. Correlations of messenger RNA expression of appetite regulators before 
weaning. 
Variables1 
    x                 y 
           r             p-value 
d 0 wt MC4R 0.544 0.0146 
d 0 wt MOR 0.404 0.0865 
d 0 wt NPY 0.155 NS2 
d 0 wt HCRT 0.028 NS 
d 0 wt AGRP -0.030 NS 
MC4R MOR 0.801 <0.0001 
MC4R NPY 0.418 0.0753 
MC4R HCRT -0.133 NS 
MC4R AGRP 0.007 NS 
MOR NPY 0.694 0.0006 
MOR HCRT -0.199 NS 
MOR AGRP -0.153 NS 
NPY HCRT -0.0231 NS 
NPY AGRP -0.097 NS 
HCRT AGRP 0.818 <0.0001 
1 d 0 wt= pre weaning body weight; MC4R= Melanocortin 4 Receptor; MOR= µ-
Opiate Receptor; NPY= Neuropeptide Y; HCRT= Hypocretin/Orexin; AGRP= Agouti 
Related Protein. 
2 NS= not significant. 
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Table 4. Correlations of messenger RNA expression of appetite regulators 24 hours 
after weaning. 
Variables1 
  x                   y 
         r        p-value 
MC4R MOR 0.515 0.0333 
MC4R NPY 0.421 0.0930 
MC4R HCRT 0.764 0.0002 
MC4R AGRP 0.283 NS2 
MOR NPY 0.612 0.0077 
MOR HCRT 0.283 NS 
MOR AGRP 0.034 NS 
NPY HCRT -0.006 NS 
NPY AGRP -0.380 NS 
HCRT AGRP 0.604 0.0051 
1 MC4R= Melanocortin 4 Receptor; MOR= µ-Opiate Receptor; NPY= Neuropeptide 
Y; HCRT= Hypocretin/Orexin; AGRP= Agouti Related Protein. 
2 NS= not significant. 
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Figures 
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Figure 1. Hypothalamic regulation of appetite. Pathway depicting the central 
hypothalamic and peripheral neuropeptides and their sites of origin. Adapted from 
Arora et al., 2006.  
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Figure 2. Average Daily Feed Intake. Average daily feed intake of pigs injected 
with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue bars) 
prior to weaning. Raw means with SE are shown. Within a graph, means with 
different letters differ (P < 0.05). 
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Figure 3. Average Daily Body Weight. Average daily body weight of pigs 
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue 
bars) prior to weaning. Raw means with SE are shown. Within a graph, means with 
different letters differ (P < 0.05). 
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Figure 4. Relative hypothalamic transcript abundance of µ-Opiate 
Receptor. Relative hypothalamic transcript abundance of the MOR gene in pigs 
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue 
bars). Raw means with SE are shown. Within a graph, means with different letters 
differ (P < 0.05).  
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Figure 5. Relative hypothalamic transcript abundance of Neuropeptide Y. 
Relative hypothalamic transcript abundance of the NPY gene in pigs injected with 
saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue bars). Raw 
means with SE are shown. Within a graph, means with different letters differ (P < 
0.05). 
 
 
 
 51 
 
Figure 6. Relative hypothalamic transcript abundance of Orexin. Relative 
hypothalamic transcript abundance of the HCRT gene in pigs injected with saline 
(VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue bars). Raw means 
with SE are shown. Within a graph, means with different letters differ (P < 0.05). 
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Figure 7. Relative hypothalamic transcript abundance of Melanocortin 4 
Receptor. Relative hypothalamic transcript abundance of the MC4R gene in pigs 
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue 
bars). Raw means with SE are shown. Within a graph, means with different letters 
differ (P < 0.05). 
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Figure 8. Relative hypothalamic transcript abundance of Agouti-Related 
Protein. Relative hypothalamic transcript abundance of the AGRP gene in pigs 
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue 
bars). Raw means with SE are shown. Within a graph, means with different letters 
differ (P < 0.05). 
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Figure 9. Linear regression of µ-Opiate Receptor and Melanocortin 4 
Receptor relative hypothalamic transcript abundance. Data from all 
treatments across all time points are included in this analysis.  
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Procedure 1. Isolation of total mRNA 
1. Homogenize tissue sample in 10-20 volumes of TRI1 
2. Incubate at room temperature for 5 min. 
3. Centrifuge at 12,000 x g for 10 min. @ 4°C 
4. Transfer supernatant to a fresh tube2 
5. Add 100 µl BCP3 per 1 ml TRI 
6. Mix well and incubate at room temperature for 15 min. 
7.  Centrifuge at 12,000 x g for 10-15 min. @ 4°C 
8. Transfer aqueous phase to a fresh tube 
9. Add 500 µl isopropanol per 1 ml TRI 
10. Mix well / vortex and incubate at room temperature for 10 min. 
11. Centrifuge at 12,000 x g for 8 min. @ 4-25°C 
12. Discard supernatant 
13. Add 1 ml 75% ethanol per 1 ml TRI 
14. Centrifuge at 7,500 x g for 5 min.  
15. Remove ethanol and briefly dry 
16. Dissolve total mRNA in buffer4 
1 TRI reagent solution (Ambion, Forest City, CA) 
2 Repeat this step if sample contains high lipid content 
3 BCP= bromochloropropane 
4 50 µl H20 
 
 
 
 57 
Procedure 2. Quality/Quantity analysis of total mRNA 
1. Add 1 µl mRNA and 99 µl H2O  + several 100 µl H2O (blanks) to a 96 well 
optically clear plate 
2. Read samples at 260 nm1 and 280 nm using mass spectrometry 
3. Subtract the blank value obtained from the pure H2O reading for both the 
260 and 280 values 
4. Obtain the quality by evaluating the 260/280 ratio2 by dividing as such 
5. Obtain the quantity by multiplying (260 nm value * 40 * 100) 3 
1 nm= nanometers 
2 ideal 260/280 ratio is 2.0 
3 ng/µl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 58 
Procedure 3. Removal of DNA contamination1 
1. Bring all samples to 500 ng/µl concentration 
2. Use 50 µl sample 
3. Add 5 µl 10X TURBO DNAse Buffer and 1 µl DNAse 
4. Mix by inversion 
5. Incubate at 37°C for 30 min. 
6. Add 5 µl re-suspended DNAse Inactivation Reagent 
7. Mix well 
8. Incubate at room temperature for 2 min.  
9.  Centrifuge at 12,000 x g for 90 sec.  
10. Transfer supernatant to RNAse-free tube 
1 Turbo DNA-Free kit (Ambion, Forest City, CA) 
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Procedure 4. cDNA synthesis by reverse transcription1 
1. Mix to obtain a total volume of 20.0 µl 
 10 µl 2X Buffer 
 1 µl 20X Enzyme Mix 
 2 µl mRNA sample 
 7 µl nuclease-free H2O 
2. Incubate reaction at 37°C for 60 min. 
3. Stop reaction by heating to 95°C for 5 min. 
4. Hold at 4°C 
5. Store cDNA2 at -20°C 
1 High Capacity RNA-to-cDNA Kit (Applied Biosystems, Forest City, CA) 
2 cDNA= complementary DNA 
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Procedure 5. Determining real-time PCR primer efficiency 
1. Create a serial dilution using pooled cDNA for each primer1 
2. Using standard cycling condiotions2, obtain the CT value for each dilution 
point 
3. Graph the log of the dilution on the X-axis and the CT value on the Y-axis 
4. Connect the points with a trend line and obtain the slope of the line 
5. Use the formula: 10[(1/|slope|)-1] to obtain the efficiency3 
1Use a wide dilution range ex: 1:10 – 1:100,000 
2 Explained in greater detail in procedure 6 
3 Pfaffl, 2001  
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Procedure 6. Real-time PCR analysis 
1. Mix to obtain a total volume of 20.0 µl 
 10 µl Gene Expression Master Mix1 
 7 µl H2O 
 2 µl cDNA2 
 1 µl Primer/Probe Mix3 
2. Run4 using the following parameters 
 2 min. at 50°C 
 8.5 min. at 95°C 
 45 Cycles of 15 sec 95°C/ 1 min. 60°C 
 Hold at 4°C 
3. Obtain target and reference gene CT values 
4. Subtract the reference gene CT  from the target gene CT = Δ CT 
5.  Transform linearly to obtain relative expression value by using the formula: 
(2- ΔCT) 5 
 1 Gene Expression Master Mix (Applied Biosystems, Forest City, CA) 
2 Use dilutions from the linear part of the efficiency graph from procedure 5 
3 Taqman Gene Expression assay primer/probe mix (Applied Biosystems, Forest 
City, CA) 
4 BIO-RAD iCycler 
5 Livak et al., 2001 
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